Literature DB >> 27642196

Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents.

Mohammad A Alam1, Kriti Arora2, Shirisha Gurrapu3, Sravan K Jonnalagadda3, Grady L Nelson3, Paul Kiprof4, Subash C Jonnalagadda5, Venkatram R Mereddy6.   

Abstract

Several derivatives of aminobenzoboroxole have been prepared starting from 2-boronobenzaldehyde. All of these derivatives have been evaluated for their anti-mycobacterial activity on Mycobacterium smegmatis and cytotoxicity on breast cancer cell line MCF7. Based on these studies, all the tested molecules have been found to be generally non-toxic and benzoboroxoles with unsubstituted (primary) amines have been found to exhibit good anti-mycobacterial activity. Some of the key compounds have been evaluated for their anti-tubercular activity on Mycobacterium tuberculosis H37Rv using 7H9 and GAST media. 7-Bromo-6-aminobenzoboroxole 4 has been identified as the lead candidate compound for further development.

Entities:  

Keywords:  Benzoxaboroles; aminobenzoxaborole; anti-tuberculosis agents; bromoaminobenzoxaborole; nitrobenzoxaborole

Year:  2016        PMID: 27642196      PMCID: PMC5021310          DOI: 10.1016/j.tet.2016.03.038

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  38 in total

Review 1.  Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting.

Authors:  Y C Manabe; W R Bishai
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

2.  Mycobacterium smegmatis and tuberculosis.

Authors:  Jaya Sivaswami Tyagi; Deepak Sharma
Journal:  Trends Microbiol       Date:  2002-02       Impact factor: 17.079

3.  Concise synthesis of omega-borono-alpha-amino acids.

Authors:  Venkata Jaganmohan Reddy; J Subash Chandra; M Venkat Ram Reddy
Journal:  Org Biomol Chem       Date:  2007-02-01       Impact factor: 3.876

4.  An improved class of sugar-binding boronic acids, soluble and capable of complexing glycosides in neutral water.

Authors:  Meenakshi Dowlut; Dennis G Hall
Journal:  J Am Chem Soc       Date:  2006-04-05       Impact factor: 15.419

5.  Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis.

Authors:  Stephen J Baker; Yong-Kang Zhang; Tsutomu Akama; Agnes Lau; Huchen Zhou; Vincent Hernandez; Weimin Mao; M R K Alley; Virginia Sanders; Jacob J Plattner
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

Review 6.  Antituberculosis drugs: ten years of research.

Authors:  Yves L Janin
Journal:  Bioorg Med Chem       Date:  2007-01-19       Impact factor: 3.641

Review 7.  Who puts the tubercle in tuberculosis?

Authors:  David G Russell
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

8.  Synthesis of α-carboranyl-α-acyloxy-amides as potential BNCT agents.

Authors:  Subash C Jonnalagadda; Jonathan S Cruz; Ryan J Connell; Patricia M Scott; Venkatram R Mereddy
Journal:  Tetrahedron Lett       Date:  2009-07-29       Impact factor: 2.415

9.  Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.

Authors:  Vinita Chaturvedi; Namrata Dwivedi; Rama P Tripathi; Sudhir Sinha
Journal:  J Gen Appl Microbiol       Date:  2007-12       Impact factor: 1.452

10.  Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis.

Authors:  Tsutomu Akama; Stephen J Baker; Yong-Kang Zhang; Vincent Hernandez; Huchen Zhou; Virginia Sanders; Yvonne Freund; Richard Kimura; Kirk R Maples; Jacob J Plattner
Journal:  Bioorg Med Chem Lett       Date:  2009-03-09       Impact factor: 2.823

View more
  4 in total

1.  Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency.

Authors:  Cecilia B Korol; Shamira J Shallom; Kriti Arora; Helena I Boshoff; Alexandra F Freeman; Alejandra King; Sonia Agrawal; Sean C Daugherty; Timothy Jancel; Juraj Kabat; Sundar Ganesan; Marina N Torrero; Elizabeth P Sampaio; Clifton Barry; Steve M Holland; Hervé Tettelin; Sergio D Rosenzweig; Adrian M Zelazny
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

2.  Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases.

Authors:  Nikos Kühl; Johannes Lang; Mila M Leuthold; Christian D Klein
Journal:  Eur J Med Chem       Date:  2022-07-11       Impact factor: 7.088

Review 3.  Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents.

Authors:  Paolo Saul Coghi; Yinghuai Zhu; Hongming Xie; Narayan S Hosmane; Yingjun Zhang
Journal:  Molecules       Date:  2021-05-31       Impact factor: 4.411

4.  Discovering simple phenylboronic acid and benzoxaborole derivatives for experimental oncology - phase cycle-specific inducers of apoptosis in A2780 ovarian cancer cells.

Authors:  Mateusz Psurski; Agnieszka Łupicka-Słowik; Agnieszka Adamczyk-Woźniak; Joanna Wietrzyk; Andrzej Sporzyński
Journal:  Invest New Drugs       Date:  2018-05-19       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.